Trial Profile
A Double-blind, Randomised, Placebo-controlled Study to Evaluate the Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2020
Price :
$35
*
At a glance
- Drugs Etamicastat (Primary)
- Indications Heart failure; Hypertension
- Focus Adverse reactions
- Sponsors Bial
- 07 Mar 2011 New trial record